Rani Therapeutics
is a biotechnology company that develops pills for the oral delivery of biologic drugs to treat patients with chronic diseases... Read moreRani Therapeutics
is a biotechnology company that develops pills for the oral delivery of biologic drugs to treat patients with chronic diseases... Read more
News
Mar 31, 2025
Seeking Alpha
Rani Therapeutics: Rani Therapeutics Holdings, Inc. 2024 Q4 - Results - Earnings Call Presentation
Mar 31, 2025
Seeking Alpha
Rani Therapeutics: Rani Therapeutics GAAP EPS of -$0.27 misses by $0.05, revenue of $1.03M
Mar 28, 2025
Benzinga
Rani Therapeutics: An Overview of Rani Therapeutics Hldgs's Earnings
Mar 26, 2025
centralcharts
Press Release: Rani Therapeutics : Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill Capsule, to Subcutaneously Administered PG-102
Mar 25, 2025
Benzinga
Rani Therapeutics: Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Feb 05, 2025
GlobalNewswire
Press Release: Rani Therapeutics : Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill HC
Oct 15, 2024
Benzinga
Rani Therapeutics: Why Rani Therapeutics Shares Are Down 23% Today
Oct 15, 2024
Marketscreener
Rani Therapeutics: Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Sep 03, 2024
Benzinga
Rani Therapeutics: Rani Therapeutics to Participate in September Investor Conferences
Aug 06, 2024
Marketscreener
Rani Therapeutics: Rani Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Rani Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10